GlaxoSmithKline Plc plans to build a new life science cluster in the UK in order to bring more resources to bear on the development of new medicines. The cluster will be located at a site in Stevenage already owned by the company. GSK plans to sell 33 acres of the plot in order to unlock £400 million in new investment from a private sector developer and build a new campus. The cluster is expected to create up to 5,000 new jobs over the next five to 10 years.
